Versartis (VSAR) Priced

Biotech developing long-acting treatments for growth hormone deficiency.

Health Care - Biotechnology

IPO Performance
Latest Trade $23.05 0.00 (0.0%)
First Day Return 49.4%
Return from IPO 9.8%
 
Versartis IPO News more
  • .
IPO Data
IPO File Date 02/18/2014
Offer Price $21.00
Price Range $19.00 - $21.00
Offer Shares (mm) 6.0
Deal Size ($mm) 126
 
IPO Data
IPO Date 03/20/2014
Offer Price $21.00
Price Range $19.00 - $21.00
Offer Shares (mm) 6.0
Deal Size ($mm) $126
 
Underwriters
more
Business Overview
Biotech developing long-acting treatments for growth hormone deficiency.
Biotech developing long-acting treatments for growth hormone deficiency.
more
Company Data
Headquarters Redwood City, CA
Founded 2008
Employees 14
Website www.versartis.com
 

Performance vs. IPO Index (IPOUSA)